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• LIVER CANCER •
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Abstract
AIM: To reveal new tumor markers and target genes from
differentially expressed genes of primary tumor samples
using cDNA microarray.
METHODS: The 33P labeled cDNAs were synthesized by
reverse transcription of message RNA from the liver
cancerous tissue and adjacent non-cancerous liver tissue
from the same patient and used to hybridize to LifeGrid 1.0
cDNA microarray blot containing 8400 known and unique
human cDNA gene targets, and an expression profile of
genes was produced in one paired human liver tumor tissue.
After a global analysis of gene expression of 8400 genes,
we selected some genes to confirm the differential expression
using Northern blot and RT-PCR.
RESULTS: Parallel analysis of the hybridized signals enabled
us to get an expression profile of genes in which about 500
genes were differentially expressed in the paired liver tumor
tissues. We identified 4 genes, the expression of three (Beclin
1, RbAp48 and Pir51) were increased and one (aldolase b)
was decreased in liver tumor tissues. In addition, the
expression of these genes in 6 hepatoma cell lines was also
showed by RT-PCR analysis.
CONCLUSION: cDNA microarray permits a high throughput
identification of changes in gene expression. The genes
encoding Beclin 1, RbAp48, Pir51 and aldolase b are first
reported that may be related with hepatocarcinoma.
Song H, Xia SL, Liao C, Li YL, Wang YF, Li TP, Zhao MJ. Genes
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INTRODUCTION
Hepatocellular carcinoma (HCC), an aggressive malignancy
with poor prognosis and one of the most common tumors in
human beings, has become a leading cause of cancer-related
death in adults from Asia and sub-Saharan-Africa[1]. The
multiple pathogenic factors, including food contamination with
aflatoxin B1 and infection with hepatitic B virus and hepatitic
C virus and the subsequent multistage pathogenesis of HCC
have been extensively studied. In addition, tumor suppressor
genes, such as Rb and p53[2], may play a significant role in
hepatocarcinogenesis. However it is not clear how these
disorders result in HCC. Recent advances in molecular genetics
have identified various genetic abnormalities in tumors.
However, little is known about the genetic alterations
responsible for specific phenotypes of HCC.
      With the advent of cDNA microarray technology, genome-
wide expression of hundreds of genes can be simultaneously
analyzed, facilitating differential expression monitoring of a
large number of activated or suppressed genes under various
biological conditions, including carcinogenesis[3-5], drug
discovery and development[6]. With cDNA microarrays, it is
now possible to perform a large-scale expression survey to
identify candidate target genes[7]. Efforts to classify human
HCC based on gene expression profile using cDNA microarray
have been successfully processed in recent year[8-12]. Shirota et al.
found that 10 genes were up-regulated and 9 genes were down-
regulated in >50% HCC and identified the changes of 22 genes
associated with the degree of differentiation of HCC[8]. Kawai
et al showed that AFP-producing hepatoma cell lines shared a
distinct expression profile of genes in various categories
compared with those of AFP-negative hepatoma cell lines and
non-hepatotic cancer cell lines[10]. Xu et al identified that 156
genes were down-regulated and up-regulated in >50% of cancer
samples of HCC[12]. So much work has focused on HCC
expression profile, however the data are still far less.
      In this study, we used cDNA microarray representing 8400
cDNA clusters to analyze HCC specific expression profile.
The aims were to identify complex alterations of genes
expression responsible for the development of HCC and to
identify differentially expressed genes and differentially
expressed novel genes of potentially biological or medical
importance for HCC. In this report, we showed that 523 genes
were differentially expressed over 4 folds in the microarray
analysis. We confirmed 4 genes which were consistently up
or down-regulated in >50% of HCC samples.
MATERIALS AND METHODS
Tumor materials and cell lines
All samples were obtained from Eastern Hepatobiliary Surgery
Hospital and Zhongshan Hospital (Shanghai, China). All
patients were diagnosed as HCC. Tissue specimens were
quickly frozen shortly after surgical resection and stored in
liquid nitrogen. Tissue for cDNA microarray hybridization was
obtained from a 47-year-old male patient with primary
hepatocellular carcinoma stage III, HBV positive.
      The HCC cell lines HepG2, SMMC-7721, Bel-7404, Bel-
7402, HuH7and the line of normal liver cells L02 were obtained
from the Cell Bank of the Chinese Academy of Sciences
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(Shanghai, P.R. China). HepG2, HuH7, Bel-7404 and Bel-7402
cells were cultured in Dulbecco’s Modified Eagle Medium
(DMED; Life Technologies Inc., Grand Island NY, U.S.A.)
supplemented with 10% fetal calf serum (FCS; Life
Technologies Inc.) and L02 and SMMC-7721 cells were
cultured in RPMI medium 1640 (Life Technologies Inc.) plus
10% FCS.
RNA preparation and poly A+ mRNA preparation
Total RNA was extracted with TRIZOL reagent (Life
Technologies, Inc., N.Y., USA). Tissue samples were
homogenized in 1ml of TRIZOL reagent per 50-100 mg of
tissue and incubated for 5 min at room temperature, then
200 ml chloroform was added and mixed vigorously and
incubated at room temperature for 2-3 min. After centrifugation
at 1 2000 rpm for 15 min at 4 , the aqueous phase was
transferred to a fresh tube, mixed with an equal volume of
isopropanol, and incubated at room temperature for 10 min.
Total RNA was collected and washed in 75% ethanol. Total
RNA was run on a denaturing formaldehyde agarose gel to
check quality. Poly A+ RNA was isolated using the oligotex
mRNA mini kit (Qiagen, Hilden, Germany) according to the
manufacture’s instructions. Two hundred micrograms of total
RNA was routinely used for mRNA isolation.
cDNA microarray hybridization
Gene expression was analyzed using the Human Life Grid 1.0
array (Incyte Genomics Inc. California, USA). Approximately
8 400 human PCR products chosen from Incyte Genomics’s
library of proprietary clones were girded onto a 12×22 cm
nylon membrane in a double-spotted pattern at a density of
approximately 16 800 spots and 27 controls. 33P-labeled cDNA
probe was generated by reverse transcription of 1 mg of each
analyzed polyA+ RNA sample in the presence of a-33P dCTP
and the percent label incorporation was not less than 40%.
Each cDNA probe was then hybridized to a microarray.
Overnight incubation was followed by stringent washing as
recommended by the manual. Membranes were exposed to
phosphor screen overnight. The data were analyzed by Incyte
Genomics.
Northern blot and semi-quantitative RT-PCR
All probes were obtained by amplification of gene fragments
by PCR under conditions listed in Table 1. For conventional
Northern blot analysis, 15 mg total RNA was fractionated by
electrophoresis through 1% agarose gel containing formaldehyde
and blotted in 20×SSC onto Hybond-N+ nylon membrane
(Amersham Pharmacia Biotech, Ltd. Buckinghamshire, UK)
by capillary force overnight. The blotted RNA was immobilized
by incubating at 80  for 1 h. Hybridization was performed at
68  in ExpressHyb hybridization buffer (CLONTECH Inc.,
California, USA) for 3 h. Membranes were washed once in
2×SSC, 0.1% SDS at room temperature, twice in 0.1×SSC,
0.1% SDS at 68  for 20 min and exposed to X-ray film (Eastman
Kodak Co., Rochester MA) at -80  for 1-6 d. Three mg total
RNA was reverse transcribed in 20 ml reaction mixture with
SuperscripTM II (Life Technologies Inc., NY., USA). The PCR
cycle number at the linear phase of amplification was chosen to
compare differential gene expression among different genes.
RESULTS
Global gene expression analysis of HCC by high density
cDNA microarray
The 33P labeled cDNAs were synthesized by RT of message
RNA from one liver cancerous tissue and adjacent normal liver
tissue from the same patient and used to hybridize to Life Grid
1.0 cDNA microarray blot. General expression profile of 8400
genes was obtained (Figure 1A). We first performed a global
analysis of gene expression of 8400 genes and compared the
gene expression profiles for normal liver and liver tumor
tissues. To eliminate data with low reliability, genes whose
expression was regarded as absent in both normal liver and
liver tumor by software analysis were excluded, and genes for
which two spots were greater than 2.5 fold different and one
of the spots was not 2 fold above background were also
excluded. There were 6542 remaining genes in normal liver
and liver tumor tissues. Fold changes in gene expression
between normal liver and liver tumor are shown in Figure 1B.
About 92% genes had no significant expression change. The
result reflected the reliability of the gene expression profile.
The scatter plot of intensity of all genes on arrays of liver tumor
and adjacent normal liver was statistically examined to evaluate
the accuracy of experiment (Figure 1C). A high correlation
was observed. This result suggested a high reliability of the
experiment for analysis of differentially displayed genes by
cDNA microarray analysis of this sample.
Characterization of expression profile of HCC
Among the 6542 genes expressed in paired liver tumor tissue,
256 genes were up-regulated and 267 genes were down-
regulated, which were greater or less than 4 fold in liver tumor
tissue. Known functioning genes differentially expressed
(>4 fold) in HCC were classified into six functional categories
with respect to selected functional properties of their products.
The six categories were included in cell division; cell, organism
defense; metabolic enzymes, transporters ion channels;
nuclear proteins; cell structure, extracellular matrix; cell
signaling, communication. The numbers of classified genes
are shown in Table 2. The group of ‘other genes’ summarized
individual genes that could not be included in any of the
above categories.
Table 1  Primer sequences and PCR conditions used for synthesis of amplicons applied as probes in Northern blot and RT-PCR
Genes name Primer (5’-3’) PCR fragment size (bp) Annealing temperature Number of cycles
Pir51 F gtggaagatgatgttggtggtg    527      58 32
R aaggcggagactctgattgg
RbAp48 F gaactgcctttctttcaatc    826      58 30
R atggctcagacacctacctc
Beclin 1 F cttaccacagcccaggcgaaac    814      58 30
R gccagagcatggagcagcaa
Aldolase b F gccactctcaacctcaatgc    423      55 32
R tctccttcccaacctaccac
b-actin F tgacggggtcacccacactgtgcc    666      60 25
R cttagaagcattgcggtggacgatg
Table 2  Classification of number of known functioning genes
differentially expressed (>4 folds) in HCC
       Number of              Number of
Gene functions    down-regulated         up-regulated
    genes in HCC           genes in HCC
Cell division  17                               14
Cell, organism defense  39                               24
Metabolic enzymes,  17                                 9
transporters ion channels
Nuclear proteins (transcription  21                               20
factors, DNA processing enzymes)
Cell structure, extracellular matrix  10                                 6
Cell signalling, communication  37                               26
EST  41                               53
Other genes  84                             102
Verification of differentially expressed genes in cDNA
microarray
To verify the data, we then performed Northern blot analysis
and RT-PCR analysis. Only genes with expression levels that
were altered by >4 fold between normal and tumor tissues
were selected. These analyses were carried out with a total 10
paired HCC samples. We identified 4 genes that were
differential expression in >50% paired samples. Three genes
were up-regulated and one was down-regulated. Northern blot
analysis of Beclin 1 and RbAp48 mRNA showed a significantly
increased expression level in 50% paired tumor samples (Figure
2), which could not be detected in normal liver tissues. Northern
blot analysis of aldolase b mRNA showed a significantly
decreased expression level in 70% paired tumor samples.
Northern blotting signal of Pir51 was difficult to obtain, the
semi-quantitative RT-PCR carried out in the linear detection
range was used to estimate the relative amount of mRNA. Pir51
mRNA was up-regulated by RT-PCR analysis in 60% paired
tumor samples (Figure 2).
Figure 2  Northern blots of RbAp48, Beclin 1 and aldolase b
genes in paired liver tumor (T) and normal liver tissues (N).
RT-PCR analysis of Pir51 in the same paired HCC samples.
18S rRNA shown as a loading control.
     In contrast we investigated the expression of Beclin 1,
RbAp48, Pir51 and aldolase b in one hepato (L02) and 5
hepatoma cells lines by RT-PCR analysis. RbAp48 was
detected in L02, Bel-7404, HepG2, Bel-7402 and HuH7, was
undetectable in SMMC-7721. Beclin 1 was detected in L02,
SMMC-7721, Bel-7404, and HepG2, was weak or undetectable
in Bel-7402 and HuH7. Pir51 was expressed in all of hepatoma
cell lines detected excluding HuH7. The data also showed that
only HepG2 cells, most of cells had not, had a weak expression
of aldolase b, (Figure 3). These results from cells coincided
with that from tissues (Figure 2). The data of 4 genes obtained
from microarray and Northern bolt or RT-PCR are summarized
in Table 3. The fold changes of the 4 genes by Northern blot
analysis were significantly consistent with cDNA microarray.
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Figure 1  Parallel analysis of gene expression in paired human liver tumor sample (A). Histogram analysis of fold change in
differentially expressed genes in cDNA microarray (B). Scatterplot of two cDNA microarray analyses of normal liver and liver
tumor samples. Each point stands for a gene with the X coordinate value as the gene expression level in the normal liver microarray
and the Y coordinate value as the gene expression level in the liver tumor microarray. A R of 0.81 was produced and suggested high
reliability of the experiments (C).
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Figure 3  RT-PCR analysis of RbAp48, Beclin 1, Pir51 and al-
dolase b expression in one hepato (L02) and 5 hepatoma cell
lines (SMMC-7721, Bel-7404, HepG2, Bel-7402, HuH7). b-actin
was shown as an internal control.
DISCUSSION
In this study, we used cDNA microarray to identify the genes
that may play roles in hepatocarcinogenesis. We demonstrated
up- or down-regulated genes in liver cancerous tissues commonly
found in patients, and compared them with those in adjacent
normal tissues. Then we selected several differentially displayed
genes for further verification by Northern blots or RT-PCR.
Four genes (Beclin 1, RbAp48, Pir51 and aldolase b) were
confirmed to have a differential expression pattern in normal
and cancerous liver tissues. The low percentage appeared to
be the heterogeneity of tumors[12]. The genes identified through
this approach are potential candidates for factors implicated
in carcinogenesis, and are useful in both cancer diagnosis and
HCC therapy.
     Beclin 1 has been found to be a novel Bcl-2-interacting
cellular protein which was mono-allelically deleted in 40-75%
of sporadic human breast cancers and ovarian cancers[13], and
also a mammalian autophagy gene that could inhibit
tumorigenesis and could be expressed at decreased levels in
human breast carcinoma[14]. It has been considered as a tumor
suppressor gene in breast cancer[14,15]. However, our results
showed that the expression of Beclin 1 mRNA was increased
in liver tumor tissues and HCC cell lines and could not be
detected in normal liver tissues. Beclin 1 has an unknown
function in HCC. Overexpression of Beclin 1 in neurons in
vivo could inhibit Sindbis virus replication, reduce central
nervous system (CNS) apoptosis, and provide protection
against fatal Sindbis virus infection, which might play a role
in host defense against Sindbis virus infection[16]. 80% of HCC
patients were infected with HBV or HCV, increased expression
of Beclin 1 might be induced by the infection of virus. The
enhanced expression of Beclin 1 in HCC provided us important
information to further determine its new biological role.
       RbAp48 was isolated as an Rb binding protein[17]. RbAp48
was found to be one of the three subunits of chromatin
assembly factor 1[18,19] and components of histone deacetylase
complexes[20,21]. RbAp48 could also interact with a complex
of CREB binding protein and phosphorylated CREB[22].
RbAp48 was physically associated in the presence of Rb and
HDAC1, suggesting that RbAp48 could be involved in
transcription repression of E2F responsive genes[23]. Binding
of RbAp48 correlated with the ability of Rb to block cell
proliferation[17,24]. Furthermore, the C. elegans homologues of
both Rb and RbAp48 were recently cloned as two proteins
that belong to the same Ras-inhibitory way[25]. However, the
mechanisms by which RbAp48 gene product regulated tumor
growth are largely unknown. RbAp48 mRNA was also shown
to increase in HCC tissues. Although the biological significance
of this finding needs further study, our results showed that
altered expression of RbAp48 gene might be related to HCC
development.
      Aldolase B, fructose-biphosphate Aldolase, an important
enzyme for glucose and fructose metabolism, is a liver-specific
gene. Some hepatic genes, for instance, albumin, ornitin
transcarbamylase and transthyretin, were down-regulated in
carcinogenesis of hepatocytes[26,27]. This down-regulation was
mainly attributed to the diminishing of some of liver-enriched
transcription factors (LETF). Kovalenko et al.[28] reported AlF-
C1 enriched in fetal and regenerating livers, and down-
regulated the aldolase B gene promoter in rat hepatoma cells.
In our results, aldolase B was down-regulated in HCC samples
and HCC cell lines, which may reflect the function change of
liver cancer from metabolism to proliferation.
     Pir51 protein could strongly interact with human Rad51
recombinase[29]. Eukaryotic Rad51 protein has been reported
to play a central role in homologous recombination by carrying
out the pairing of homologous DNA molecules and initiating
the strand exchange reaction[30,31] and mammalian Rad51 was
essential for cell proliferation. Rad51 activity is regulated by
its associated proteins. Pir51 protein could bind to both single
and double stranded DNA and was capable of aggregating
DNA[29]. However, functional significance of biochemical
properties of pir51 is unclear.
      In conclusion, our data demonstrate that profiling of HCC
samples can help reveal genes that are commonly expressed
in HCC. Information from these studies may be useful in the
development of therapeutic drugs for liver cancer.
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